Vanda Pharmaceuticals, Inc. (VNDA)
6.07
-0.07
(-1.14%)
USD |
NASDAQ |
Dec 09, 16:00
6.07
0.00 (0.00%)
After-Hours: 18:02
Vanda Pharmaceuticals EPS Diluted (Quarterly): -0.3822 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| ADMA Biologics, Inc. | 0.1489 |
| Aldeyra Therapeutics, Inc. | -0.1279 |
| Exelixis, Inc. | 0.695 |
| Anavex Life Sciences Corp. | -0.1144 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.59M |
| Revenue (Quarterly) | 56.26M |
| Total Expenses (Quarterly) | 78.84M |
| Enterprise Value | 80.02M |
| Gross Profit Margin (Quarterly) | 91.64% |
| Profit Margin (Quarterly) | -40.15% |
| Earnings Yield | -23.58% |
| Normalized Earnings Yield | -23.58 |